| Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage G Castellano, R Melchiorre, A Loverre, P Ditonno, V Montinaro, M Rossini, ... The American journal of pathology 176 (4), 1648-1659, 2010 | 183 | 2010 |
| Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis CJ Hill, AE Courtney, CR Cardwell, AP Maxwell, G Lucarelli, M Veroux, ... Nephrology Dialysis Transplantation 30 (8), 1403-1411, 2015 | 181 | 2015 |
| Patient and partner satisfaction after AMS inflatable penile prosthesis implant C Bettocchi, F Palumbo, M Spilotros, G Lucarelli, S Palazzo, M Battaglia, ... The journal of sexual medicine 7 (1_Part_1), 304-309, 2010 | 135 | 2010 |
| Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma G Lucarelli, V Galleggiante, M Rutigliano, F Sanguedolce, S Cagiano, ... Oncotarget 6 (15), 13371, 2015 | 133 | 2015 |
| Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway C Curci, G Castellano, A Stasi, C Divella, A Loverre, M Gigante, S Simone, ... Nephrology Dialysis Transplantation 29 (4), 799-808, 2014 | 106 | 2014 |
| Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial … G Lucarelli, M Rutigliano, F Sallustio, D Ribatti, A Giglio, ML Signorile, ... Aging (Albany NY) 10 (12), 3957, 2018 | 99 | 2018 |
| Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml G Lucarelli, M Fanelli, AMV Larocca, CA Germinario, M Rutigliano, ... The Prostate 72 (15), 1611-1621, 2012 | 98 | 2012 |
| Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma G Lucarelli, D Loizzo, R Franzin, S Battaglia, M Ferro, F Cantiello, ... Expert review of molecular diagnostics 19 (5), 397-407, 2019 | 97 | 2019 |
| Complement Modulation of Anti‐Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function G Castellano, A Intini, A Stasi, C Divella, M Gigante, P Pontrelli, R Franzin, ... American Journal of Transplantation 16 (1), 325-333, 2016 | 87 | 2016 |
| Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer G Lucarelli, M Rutigliano, C Bettocchi, S Palazzo, A Vavallo, ... The Journal of urology 190 (6), 2271-2277, 2013 | 86 | 2013 |
| An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer M Ferro, MD Vartolomei, GI Russo, F Cantiello, ARA Farhan, ... World journal of urology 37, 507-514, 2019 | 77 | 2019 |
| Delayed relief of ureteral obstruction is implicated in the long-term development of renal damage and arterial hypertension in patients with unilateral ureteral injury G Lucarelli, P Ditonno, C Bettocchi, G Grandaliano, L Gesualdo, ... The Journal of Urology, 2013 | 77 | 2013 |
| The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation C Bianchi, C Meregalli, S Bombelli, V Di Stefano, F Salerno, B Torsello, ... Oncotarget 8 (69), 113502, 2017 | 71 | 2017 |
| Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer G Lucarelli, M Rutigliano, V Galleggiante, A Giglio, S Palazzo, M Ferro, ... Expert review of molecular diagnostics 15 (9), 1211-1224, 2015 | 69 | 2015 |
| Emerging Urinary Markers of Renal Injury in Obstructive Nephropathy G Lucarelli, V Mancini, V Galleggiante, M Rutigliano, A Vavallo, ... BioMed Research International 2014, 2014 | 68 | 2014 |
| Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma G Lucarelli, M Rutigliano, M Ferro, A Giglio, A Intini, F Triggiano, ... Urologic Oncology: Seminars and Original Investigations 35 (7), 461. e15-461 …, 2017 | 67 | 2017 |
| The emerging role of obesity, diet and lipid metabolism in prostate cancer M Ferro, D Terracciano, C Buonerba, G Lucarelli, D Bottero, S Perdonà, ... Future Oncology 13 (3), 285-293, 2017 | 65 | 2017 |
| Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer MD Vartolomei, M Ferro, F Cantiello, G Lucarelli, S Di Stasi, R Hurle, ... Clinical genitourinary cancer 16 (6), 445-452, 2018 | 62 | 2018 |
| Biomarkers in localized prostate cancer M Ferro, C Buonerba, D Terracciano, G Lucarelli, V Cosimato, D Bottero, ... Future Oncology 12 (3), 399-411, 2016 | 62 | 2016 |
| Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives OS Tătaru, MD Vartolomei, JJ Rassweiler, O Virgil, G Lucarelli, F Porpiglia, ... Diagnostics 11 (2), 354, 2021 | 60 | 2021 |
Matteo FerroEuropean Institute of Oncology
